Cardiac Injury Is a Common Postmortem Finding in Thrombotic Thrombocytopenic Purpura Patients: Is Empiric Cardiac Monitoring and Protection Needed?

Therapeutic Apheresis and Dialysis

Volumn 19, Issue 1, 2015, Pages 87-92

  Nichols, Larry ^a,c   Berg, Aaron ^a   Rollins Raval, Marian A ^a,d   Raval, Jay S ^a,b,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myocardial infarction; Acute myocardial ischemia; Autopsy; Causes of death; Thrombocytopenia; Thrombotic thrombocytopenic purpura

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANEMIA; ARTICLE; AUTOPSY; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN INFARCTION; CAUSE OF DEATH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART ARREST; HEART INFARCTION; HEART INJURY; HISTOPATHOLOGY; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; KIDNEY HEMORRHAGE; KIDNEY INFARCTION; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG INFARCTION; MALE; MIDDLE AGED; NAUSEA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PRURITUS; REMISSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TIME OF DEATH; UREA NITROGEN BLOOD LEVEL; VERY ELDERLY; YOUNG ADULT; AGE; COHORT ANALYSIS; MORTALITY; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEEDS ASSESSMENT; PATHOLOGY; PHYSIOLOGIC MONITORING; PLASMAPHERESIS; PROCEDURES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

ADULT; AGE FACTORS; AGED; AUTOPSY; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEEDS ASSESSMENT; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 84922692498     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12191     Document Type: Article

References (20)

1. Kiss JE. Thrombotic thrombocytopenic purpura: recognition and management. Int J Hematol 2010;91:36-45.
2. Furlan M, Robles R, Galbusera M etal. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584.
3. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594.
4. Tsai HM. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 2010;91:1-19.
5. Benhamou Y, Assie C, Boelle PY etal. Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Haematologica 2012;97:1181-1186.
6. Rock GA, Shumak KH, Buskard NA etal. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397.
7. Szczepiorkowski ZM, Winters JL, Bandarenko N etal. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177.
8. Alfsen GC, Maehlen J. The value of autopsies for determining the cause of death. Tidsskr Nor Laegeforen 2012;132:147-151.
9. George JN, Chen Q, Deford CC, Al-Nouri Z. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher 2012;27:302-311.
10. Vesely SK, George JN, Lammle B etal. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;102:60-68.
11. Cataland SR, Peyvandi F, Mannucci PM etal. Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura. Am J Hematol 2012;87:430-432.
12. Gandhi K, Aronow WS, Desai H etal. Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: a single-center experience. Clin Cardiol 2010;33:213-216.
13. Hosler GA, Cusumano AM, Hutchins GM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med 2003;127:834-839.
14. Berkowitz LR, Dalldorf FG, Blatt PM. Thrombotic thrombocytopenic purpura: a pathology review. JAMA 1979;241:1709-1710.
15. James TN, Monto RW. Pathology of the cardiac conduction system in thrombotic thrombocytopenic purpura. Ann Intern Med 1966;65:37-43.
16. Ridolfi RL, Hutchins GM, Bell WR. The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients. Ann Intern Med 1979;91:357-363.
17. Bell MD, Barnhart JS, Jr, Martin JM. Thrombotic thrombocytopenic purpura causing sudden, unexpected death-a series of eight patients. J Forensic Sci 1990;35:601-613.
18. Hawkins BM, Abu-Fadel M, Vesely SK, George JN. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion 2008;48:382-392.
19. McCarthy LJ, Danielson CF, Skipworth EM, Peters SL, Miraglia CC, Antony AC. Myocardial infarction/injury is relatively common at presentation of acute thrombotic thrombocytopenic purpura: the Indiana University experience. Ther Apher 2002;6:2-4.
20. Patschan D, Witzke O, Duhrsen U, Erbel R, Philipp T, Herget-Rosenthal S. Acute myocardial infarction in thrombotic microangiopathies-clinical characteristics, risk factors and outcome. Nephrol Dial Transplant 2006;21:1549-1554.